Smad proteins regulate transcriptional induction of the SM22α gene by TGF‐β

Smad proteins transduce signals from transforming growth factor-beta (TGF-beta) receptors and regulate transcription of target genes. TGF-beta is implicated in the regulation of the smooth muscle cell specific gene SM22alpha, but little is known about how Smads are involved in SM22alpha gene transcription. In this report, we demonstrate that TGF-beta activation of the SM22alpha promoter is Smad dependent in C3H10T1/2 cells, BALB 3T3 cells and neural crest Monc-1 cells. We find that the promoter region from -162 to +41 is sufficient to up-regulate the reporter gene upon TGF-beta induction. Smad3, Smad1 and Smad4 are found in TGF-beta inducible complexes that bind to a region containing a Smad binding site (SBS) and a medea box. Both the SBS and medea box are necessary for complex formation and are functionally important. Smad4 is limiting for TGF-beta induction, and Smad3, but not Smad1, significantly contributes to maximal activation. Time course luciferase assays and time course gel mobility shift assays reveal that the Smad3/4 complex is largely responsible for the immediate response of the SM22alpha promoter to TGF-beta induction, and also contributes to the maximal promoter activity. We further demonstrate that AP-1 elements contribute to induction of the SM22alpha promoter by TGF-beta.

[1]  P. ten Dijke,et al.  Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter* , 2002, The Journal of Biological Chemistry.

[2]  石田 済.  Smad6 Is a Smad1/5-induced Smad Inhibitor , 2001 .

[3]  Shuibang Wang,et al.  Transforming Growth Factor-β and Ciliary Neurotrophic Factor Synergistically Induce Vasoactive Intestinal Peptide Gene Expression through the Cooperation of Smad, STAT, and AP-1 Sites* , 2001, The Journal of Biological Chemistry.

[4]  R. Kucherlapati,et al.  Functional Characterization of Transforming Growth Factor β Signaling in Smad2- and Smad3-deficient Fibroblasts* , 2001, The Journal of Biological Chemistry.

[5]  A. Roberts,et al.  Smad3/AP-1 interactions control transcriptional responses to TGF-β in a promoter-specific manner , 2001, Oncogene.

[6]  C. Clendenin,et al.  Binding of Serum Response Factor to CArG Box Sequences Is Necessary but Not Sufficient to Restrict Gene Expression to Arterial Smooth Muscle Cells* , 2001, The Journal of Biological Chemistry.

[7]  P. Angel,et al.  Induction of the AP-1 members c-Jun and JunB by TGF-β/Smad suppresses early Smad-driven gene activation , 2001, Oncogene.

[8]  M. Lu,et al.  Analysis of SM22α-Deficient Mice Reveals Unanticipated Insights into Smooth Muscle Cell Differentiation and Function , 2001, Molecular and Cellular Biology.

[9]  R. Derynck,et al.  Structural and Functional Characterization of the Transforming Growth Factor-β-induced Smad3/c-Jun Transcriptional Cooperativity* , 2000, The Journal of Biological Chemistry.

[10]  Christopher P. Regan,et al.  Positive- and Negative-acting Krüppel-like Transcription Factors Bind a Transforming Growth Factor β Control Element Required for Expression of the Smooth Muscle Cell Differentiation Marker SM22α in Vivo * , 2000, The Journal of Biological Chemistry.

[11]  A. Atfi,et al.  Tumor Necrosis Factor-α Inhibits Transforming Growth Factor-β /Smad Signaling in Human Dermal Fibroblasts via AP-1 Activation* , 2000, The Journal of Biological Chemistry.

[12]  J. Gauthier,et al.  c-Jun Inhibits Transforming Growth Factor β-mediated Transcription by Repressing Smad3 Transcriptional Activity* , 2000, The Journal of Biological Chemistry.

[13]  J. Massagué,et al.  Transcriptional control by the TGF‐β/Smad signaling system , 2000 .

[14]  K. M. Mulder,et al.  Role of Ras and Mapks in TGFβ signaling , 2000 .

[15]  M. Goumans,et al.  Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. , 2000, The International journal of developmental biology.

[16]  P. Carmeliet.  Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[17]  K. Miyazono,et al.  Smad6 Is a Smad1/5-induced Smad Inhibitor , 2000, The Journal of Biological Chemistry.

[18]  T. Shioda,et al.  The Smad4 Activation Domain (SAD) Is a Proline-rich, p300-dependent Transcriptional Activation Domain* , 2000, The Journal of Biological Chemistry.

[19]  G. Owens,et al.  Positive- and Negative-acting Krüppel-like Transcription Factors Bind a Transforming Growth Factor b Control Element Required for Expression of the Smooth Muscle Cell Differentiation Marker SM22a in Vivo* , 2000 .

[20]  C. Heldin,et al.  Specificity, diversity, and regulation in TGF‐β superfamily signaling , 1999 .

[21]  Xing Shen,et al.  Smads bind directly to the Jun family of AP-1 transcription factors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Jian-ming Li,et al.  Smad3-Smad4 and AP-1 Complexes Synergize in Transcriptional Activation of the c-Jun Promoter by Transforming Growth Factor β , 1999, Molecular and Cellular Biology.

[23]  C. Little,et al.  Developmental Biology of the Vascular Smooth Muscle Cell: Building a Multilayered Vessel Wall , 1999, Journal of Vascular Research.

[24]  Jian-ming Li,et al.  Smad 3-Smad 4 and AP-1 Complexes Synergize in Transcriptional Activation of the c-Jun Promoter by Transforming Growth Factor b , 1999 .

[25]  G. Owens.  Molecular control of vascular smooth muscle cell differentiation. , 1998, Acta physiologica Scandinavica.

[26]  R. Derynck,et al.  Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription , 1998, Nature.

[27]  M. Frasch,et al.  Smad proteins act in combination with synergistic and antagonistic regulators to target Dpp responses to the Drosophila mesoderm. , 1998, Genes & development.

[28]  A. Roberts,et al.  Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. , 1998, Genes & development.

[29]  Denis Vivien,et al.  Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.

[30]  A. Roberts,et al.  Smad-dependent Transcriptional Activation of Human Type VII Collagen Gene (COL7A1) Promoter by Transforming Growth Factor-β* , 1998, The Journal of Biological Chemistry.

[31]  K. Hirschi,et al.  PDGF, TGF-β, and Heterotypic Cell–Cell Interactions Mediate Endothelial Cell–induced Recruitment of 10T1/2 Cells and Their Differentiation to a Smooth Muscle Fate , 1998, The Journal of cell biology.

[32]  K. Kinzler,et al.  Human Smad3 and Smad4 are sequence-specific transcription activators. , 1998, Molecular cell.

[33]  Xiao-Fan Wang,et al.  Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein , 1997, Molecular and cellular biology.

[34]  Kirby D. Johnson,et al.  Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic , 1997, Nature.

[35]  D. Anderson,et al.  Immortalization and controlled in vitro differentiation of murine multipotent neural crest stem cells. , 1997, Journal of neurobiology.

[36]  A. Roberts,et al.  Characterization of Functional Domains within Smad4/DPC4* , 1997, The Journal of Biological Chemistry.

[37]  G. Owens,et al.  A Transforming Growth Factor β (TGFβ) Control Element Drives TGFβ-induced Stimulation of Smooth Muscle α-Actin Gene Expression in Concert with Two CArG Elements* , 1997, The Journal of Biological Chemistry.

[38]  C. Clendenin,et al.  A serum response factor-dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineages , 1997, Molecular and cellular biology.

[39]  G. Owens,et al.  A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements. , 1997, The Journal of biological chemistry.

[40]  J. Small,et al.  The SM 22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice. , 1996, Development.

[41]  K. Takahashi,et al.  The 5'-flanking region of the human smooth muscle cell calponin gene contains a cis-acting domain for interaction with a methylated DNA-binding transcription repressor. , 1996, Journal of biochemistry.

[42]  S. White,et al.  Identification of Promoter Elements Involved in Cell-specific Regulation of Rat Smooth Muscle Myosin Heavy Chain Gene Transcription* , 1996, The Journal of Biological Chemistry.

[43]  David J. Anderson,et al.  Alternative Neural Crest Cell Fates Are Instructively Promoted by TGFβ Superfamily Members , 1996, Cell.

[44]  E. Olson,et al.  SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. , 1996, Circulation research.

[45]  P. Rotwein,et al.  Regulation of insulin-like growth factor I transcription by cyclic adenosine 3',5'-monophosphate (cAMP) in fetal rat bone cells through an element within exon 1: protein kinase A-dependent control without a consensus AMP response element. , 1995, Endocrinology.

[46]  E. Morrisey,et al.  Structure and Expression of a Smooth Muscle Cell-specific Gene, SM22α (*) , 1995, The Journal of Biological Chemistry.

[47]  J. Small,et al.  Calponin and SM 22 as differentiation markers of smooth muscle: spatiotemporal distribution during avian embryonic development. , 1993, Differentiation; research in biological diversity.

[48]  D. Foster,et al.  The 5'-flanking region of the mouse vascular smooth muscle alpha-actin gene contains evolutionarily conserved sequence motifs within a functional promoter. , 1990, The Journal of biological chemistry.